April 30, 2024Open Access

Area Vulnerability and Disparities in Therapy for Patients With Metastatic Renal Cell Carcinoma

Key Points

Key points are not available for this paper at this time.

Abstract

Area-level measures of sociodemographic disadvantage may be associated with racial and ethnic disparities with respect to receipt of treatment for metastatic renal cell carcinoma (mRCC) but have not been investigated previously, to our knowledge.

KI fragen

Bookmark

View Full Paper

Cite This Study

Rahman et al. (Tue,) studied this question.

synapsesocial.com/papers/68e6cbe9b6db6435876498f7 https://doi.org/https://doi.org/10.1001/jamanetworkopen.2024.8747

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Comorbidity Measures for Use with Administrative Data1998 · 9,946 citations
2Association of high cost sharing and targeted therapy initiation among elderly Medicare patients with metastatic renal cell carcinoma2017 · 28 citations
3Local Residential Segregation Matters: Stronger Association of Census Tract Compared to Conventional City-Level Measures with Fatal and Non-Fatal Assaults (Total and Firearm Related), Using the Index of Concentration at the Extremes (ICE) for Racial, Economic, and Racialized Economic Segregation, Massachusetts (US), 1995–20102017 · 170 citations
4Neighborhood and Individual Socioeconomic Disadvantage and Survival Among Patients With Nonmetastatic Common Cancers2021 · 172 citations
5The Impact of Racial Residential Segregation on Colorectal Cancer Outcomes and Treatment2020 · 63 citations

KI fragen

Bookmark

View Full Paper